用于新型隐球菌格鲁比变种的三种半乳糖诱导型启动子。
Three galactose inducible promoters for use in C. neoformans var. grubii.
作者信息
Ruff Jack A, Lodge Jennifer K, Baker Lorina G
机构信息
Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, 1100 S. Grand Boulevard, Saint Louis, MO 63104, USA.
出版信息
Fungal Genet Biol. 2009 Jan;46(1):9-16. doi: 10.1016/j.fgb.2008.10.003. Epub 2008 Oct 14.
Abstract
Cryptococcus neoformans is the causative agent of cryptococcal meningoencephalitis, most frequently occurring in immunocompromised individuals. There are three varieties of C. neoformans, var. grubii, var. neoformans, and var. gatti. Worldwide var. grubii is the most prevalent clinical isolate. However, few tools for the study of essential genes in var. grubii exist. Here we describe three endogenous inducible promoters for use in the study of this important opportunistic pathogen. We identified eight potential homologs of S. cerevisiae galactose genes in var. grubii. We found that GAL1, GAL7, and UGE2 were regulated by glucose and galactose and can be used successfully during mating. Our analysis indicated these promoters should prove to be excellent tools for analysis of genes in var. grubii.
摘要
新型隐球菌是隐球菌性脑膜脑炎的病原体，最常发生于免疫功能低下的个体。新型隐球菌有三个变种，即格氏变种、新型变种和加蒂变种。在全球范围内，格氏变种是最常见的临床分离株。然而，用于研究格氏变种中必需基因的工具很少。在此，我们描述了三种内源性诱导型启动子，用于研究这种重要的机会性病原体。我们在格氏变种中鉴定出了酿酒酵母半乳糖基因的八个潜在同源物。我们发现GAL1、GAL7和UGE2受葡萄糖和半乳糖调控，并且在交配过程中可以成功使用。我们的分析表明，这些启动子应被证明是分析格氏变种中基因的优秀工具。
相似文献
1
Three galactose inducible promoters for use in C. neoformans var. grubii.
Fungal Genet Biol. 2009 Jan;46(1):9-16. doi: 10.1016/j.fgb.2008.10.003. Epub 2008 Oct 14.
2
Galactose-Inducible promoters in Cryptococcus neoformans var. grubii.
Methods Mol Biol. 2012;845:211-26. doi: 10.1007/978-1-61779-539-8_14.
3
A unique chromosomal rearrangement in the Cryptococcus neoformans var. grubii type strain enhances key phenotypes associated with virulence.
mBio. 2012 Feb 28;3(2). doi: 10.1128/mBio.00310-11. Print 2012.
4
The Cryptococcus neoformans GAL7 gene and its use as an inducible promoter.
Mol Microbiol. 1995 Jun;16(6):1099-109. doi: 10.1111/j.1365-2958.1995.tb02335.x.
5
Molecular cloning, phylogenetic analysis and three-dimensional modeling of Cu,Zn superoxide dismutase (CnSOD1) from three varieties of Cryptococcus neoformans.
Gene. 2001 May 2;268(1-2):41-51. doi: 10.1016/s0378-1119(01)00408-5.
6
Antifungal susceptibility testing with YeastONE™ is not predictive of clinical outcomes of Cryptococcus neoformans var. grubii fungemia.
Med Mycol. 2021 Nov 3;59(11):1114-1121. doi: 10.1093/mmy/myab046.
7
Exploration of whole-genome responses of the human AIDS-associated yeast pathogen Cryptococcus neoformans var grubii: nitric oxide stress and body temperature.
Curr Genet. 2007 Sep;52(3-4):137-48. doi: 10.1007/s00294-007-0147-9. Epub 2007 Jul 28.
8
Molecular genetic analyses of mating pheromones reveal intervariety mating or hybridization in Cryptococcus neoformans.
Infect Immun. 2002 Sep;70(9):5225-35. doi: 10.1128/IAI.70.9.5225-5235.2002.
9
Comparative genomics of Cryptococcus neoformans var. grubii associated with meningitis in HIV infected and uninfected patients in Vietnam.
PLoS Negl Trop Dis. 2017 Jun 14;11(6):e0005628. doi: 10.1371/journal.pntd.0005628. eCollection 2017 Jun.
10
In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India.
J Med Microbiol. 2011 Jul;60(Pt 7):961-967. doi: 10.1099/jmm.0.029025-0. Epub 2011 Mar 10.
引用本文的文献
1
Intrinsic and extrinsic factors affecting the evolution of virulence in the HIV-associated opportunistic human fungal pathogen .
Virulence. 2025 Dec;16(1):2546067. doi: 10.1080/21505594.2025.2546067. Epub 2025 Aug 14.
2
Phenotypic landscape of an invasive fungal pathogen reveals its unique biology.
Cell. 2025 Jun 9. doi: 10.1016/j.cell.2025.05.017.
3
Adaptation of the tetracycline-repressible system for modulating the expression of essential genes in .
mSphere. 2025 May 27;10(5):e0101824. doi: 10.1128/msphere.01018-24. Epub 2025 May 1.
4
Phenotypic landscape of a fungal meningitis pathogen reveals its unique biology.
bioRxiv. 2024 Oct 29:2024.10.22.619677. doi: 10.1101/2024.10.22.619677.
5
Gene Silencing via RNA Interference in Cryptococcus.
Methods Mol Biol. 2024;2775:91-106. doi: 10.1007/978-1-0716-3722-7_7.
6
Cryptococcus neoformans Database in Synthetic Biology Open Language.
Microbiol Resour Announc. 2022 Sep 15;11(9):e0019822. doi: 10.1128/mra.00198-22. Epub 2022 Aug 24.
7
Genetic analysis of Hsp90 function in Cryptococcus neoformans highlights key roles in stress tolerance and virulence.
Genetics. 2022 Jan 4;220(1). doi: 10.1093/genetics/iyab164.
8
Dynamic genome plasticity during unisexual reproduction in the human fungal pathogen Cryptococcus deneoformans.
PLoS Genet. 2021 Nov 29;17(11):e1009935. doi: 10.1371/journal.pgen.1009935. eCollection 2021 Nov.
9
Application of an optimized annotation pipeline to the Cryptococcus deuterogattii genome reveals dynamic primary metabolic gene clusters and genomic impact of RNAi loss.
G3 (Bethesda). 2021 Feb 9;11(2). doi: 10.1093/g3journal/jkaa070.
10
Treatment strategies for cryptococcal infection: challenges, advances and future outlook.
Nat Rev Microbiol. 2021 Jul;19(7):454-466. doi: 10.1038/s41579-021-00511-0. Epub 2021 Feb 8.
本文引用的文献
1
PKC1 is essential for protection against both oxidative and nitrosative stresses, cell integrity, and normal manifestation of virulence factors in the pathogenic fungus Cryptococcus neoformans.
Eukaryot Cell. 2008 Oct;7(10):1685-98. doi: 10.1128/EC.00146-08. Epub 2008 Aug 8.
2
Systematic capsule gene disruption reveals the central role of galactose metabolism on Cryptococcus neoformans virulence.
Mol Microbiol. 2007 May;64(3):771-81. doi: 10.1111/j.1365-2958.2007.05695.x.
3
Cell wall integrity is dependent on the PKC1 signal transduction pathway in Cryptococcus neoformans.
Mol Microbiol. 2005 Oct;58(2):393-408. doi: 10.1111/j.1365-2958.2005.04843.x.
4
The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans.
Science. 2005 Feb 25;307(5713):1321-4. doi: 10.1126/science.1103773. Epub 2005 Jan 13.
5
An efficiently regulated promoter system for Cryptococcus neoformans utilizing the CTR4 promoter.
Yeast. 2004 Aug;21(11):919-26. doi: 10.1002/yea.1139.
6
The enzymatic transformation of uridine diphosphate glucose into a galactose derivative.
Arch Biochem Biophys. 1951 Sep;33(2):186-90. doi: 10.1016/0003-9861(51)90096-3.
7
Sexual cycle of Cryptococcus neoformans var. grubii and virulence of congenic a and alpha isolates.
Infect Immun. 2003 Sep;71(9):4831-41. doi: 10.1128/IAI.71.9.4831-4841.2003.
8
A yeast under cover: the capsule of Cryptococcus neoformans.
Eukaryot Cell. 2003 Aug;2(4):655-63. doi: 10.1128/EC.2.4.655-663.2003.
9
Genetics of Cryptococcus neoformans.
Annu Rev Genet. 2002;36:557-615. doi: 10.1146/annurev.genet.36.052402.152652. Epub 2002 Jun 11.
10
A PCR-based strategy to generate integrative targeting alleles with large regions of homology.
Microbiology (Reading). 2002 Aug;148(Pt 8):2607-2615. doi: 10.1099/00221287-148-8-2607.
Zotero 插件